Transactivation of EGFR by LCK underlies an activity-defined dependency that predicts response to EGFR inhibition in cholangiocarcinoma

Cholangiocarcinoma (CCA) is an aggressive biliary tract malignancy with limited molecularly guided treatment options. The Src-family kinase LCK is a therapeutic vulnerability in CCA, yet its canonical T-cell substrates are minimally expressed in CCA cells, leaving its downstream effectors undefined. Unbiased proximity labeling in HuCCT1 cells identified EGFR within the LCK signaling neighborhood. LCK depletion or inhibition reduced EGFR phosphorylation, whereas recombinant LCK increased EGFR phosphorylation in a cell-free assay, supporting a noncanonical role for LCK upstream of EGFR. Given the failure of EGFR-directed therapies in unselected CCA populations, we hypothesized that EGFR activity, rather than abundance or mutation status, identifies EGFR-dependent tumors. Among 28 patient-derived xenografts ranked by pretreatment substrate-inferred EGFR activity, the activity score correctly classified afatinib response in all six models tested. An analogous EGFR activity score stratified primary tumors in two human CCA cohorts. Together, these findings identify a therapeutically actionable LCK-EGFR signaling axis and nominate EGFR activity as a functional biomarker to guide tumor selection for EGFR-directed therapy in CCA, warranting prospective clinical validation.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-12
DOI
https://doi.org/10.64898/2026.11.11.765714
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Transactivation of EGFR by LCK underlies an activity-defined dependency that predicts response to EGFR inhibition in cholangiocarcinoma

Dong‐Gi Mun, Gregory James Gores, Meina Cai, Enis Özmert et al.
bioRxiv (Cold Spring Harbor Laboratory)
Cholangiocarcinoma and Gallbladder Cancer Studies
preprint

Transactivation of EGFR by LCK underlies an activity-defined dependency that predicts response to EGFR inhibition in cholangiocarcinoma

Dong‐Gi Mun, Gregory James Gores, Meina Cai, Enis Özmert, Akhilesh Pandey, Brandon A. Wilbanks, Mark Joseph Truty, Danielle Marie Carlson, Haidong Dong, Ryan D. Watkins, Erik Jessen, Jennifer L. Tomlinson, Amro M. Abdelrahman, Hendrien Kuipers, Caitlin B. Conboy, Nathan W. Werneburg
preprint en

Abstract

Cholangiocarcinoma (CCA) is an aggressive biliary tract malignancy with limited molecularly guided treatment options. The Src-family kinase LCK is a therapeutic vulnerability in CCA, yet its canonical T-cell substrates are minimally expressed in CCA cells, leaving its downstream effectors undefined. Unbiased proximity labeling in HuCCT1 cells identified EGFR within the LCK signaling neighborhood. LCK depletion or inhibition reduced EGFR phosphorylation, whereas recombinant LCK increased EGFR phosphorylation in a cell-free assay, supporting a noncanonical role for LCK upstream of EGFR. Given the failure of EGFR-directed therapies in unselected CCA populations, we hypothesized that EGFR activity, rather than abundance or mutation status, identifies EGFR-dependent tumors. Among 28 patient-derived xenografts ranked by pretreatment substrate-inferred EGFR activity, the activity score correctly classified afatinib response in all six models tested. An analogous EGFR activity score stratified primary tumors in two human CCA cohorts. Together, these findings identify a therapeutically actionable LCK-EGFR signaling axis and nominate EGFR activity as a functional biomarker to guide tumor selection for EGFR-directed therapy in CCA, warranting prospective clinical validation.

bioRxiv (Cold Spring Harbor Laboratory)
Mayo Clinic (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)
Center for Cell Signaling in Gastroenterology, Mayo Clinic
Good health and well-being
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon